Impaired serotype-specific immune function following pneumococcal vaccination in infants with prior carriage
Paul V Licciardi, Fiona M Russell, Anne Balloch, Robert L Burton, Moon H Nahm, Gwendolyn Gilbert, Mimi LK Tang, Edward K Mulholland
Vaccine | ELSEVIER SCI LTD | Published : 2014
Related Projects (1)
Awarded by National Institute of Allergy and Infectious Diseases (NIAID)
Awarded by Australian National Health and Medical Research Council (NHMRC)
Awarded by National Institutes of Health
Funding source: This work was supported by grants from the National Institute of Allergy and Infectious Diseases (NIAID; 2 U01 AI052337-05), the Australian National Health and Medical Research Council (NHMRC grant no. 251648), and the Victorian Government's Operational Infrastructure Support Program. Pneumovax was kindly donated by CSL Biotherapies, Australia. P.V.L. is a recipient of an NHMRC Training Fellowship. M.H.N. is supported by National Institutes of Health contract AI-30021.